68.7	Vioxx	Rofecoxib	Rofecoxib ( ) is a nonsteroidal anti-inflammatory drug that has now been withdrawn over safety concerns. It was marketed by Merck &amp; Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhoea. Rofecoxib was approved by the Food and Drug Administration (FDA) on May 20, 1999, and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx.	http://upload.wikimedia.org/wikipedia/commons/thumb/2/28/Rofecoxib.svg/167px-Rofecoxib.svg.png
